2m 2m 2m 2m 2m 2m 2m
- N/AMarket Cap
- -89.63%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Zhengye-A (ZYBT)
Key Performance
More- Earnings Score: N/A
- Momentum Score: 39
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
12 Health Care Stocks Moving In Friday's After-Market Session
Multiple healthcare stocks experienced significant price movements during Friday's after-market trading session, with some companies seeing notable gains while others experienced declines.
09/26/2025, 5:06 PM • Benzinga
Peers
Statistics
MoreInformation as of 06/23/2026
Company Profile
Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in the People's Republic of China. The company offers vaccines for swine, cattle, goats, sheep, poultry, and dogs, as well as monovalent vaccine, polyvalent vaccine, combined vaccine, and combined and polyvalent vaccine. It also develops vaccines for household animals, including rabies vaccine and Strain Flury LEP for dogs. In addition, the company exports its products to Vietnam, Pakistan, and Egypt. It serves direct-end customers, including livestock farmers and local governments; and domestic distributors and exporting distributors. The company was incorporated in 2004 and is based in Jilin, China. Zhengye Biotechnology Holding Limited operates as a subsidiary of Securingium Holding Limited.
Key Executives
- Yuhong Cheng
- Zhongyao Liu
- Ping Wang
- Songlin Song
- Aiden Han
Current Ownership Distribution
- Other47.2M (99.59%)
- Institutions121,043 (0.26%)
- Mutual Funds71,299 (0.15%)
- Insiders0 (0.00%)